Who are Ibuprofen and paracetamol's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ibuprofen-and-paracetamol.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Ibuprofen and paracetamol — Competitive Intelligence Brief

Ibuprofen and paracetamol (Ibuprofen and paracetamol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nonsteroidal anti-inflammatory drug (NSAID) and analgesic. Area: Oncology, Pain management, and Gastroenterology.

phase 2 Nonsteroidal anti-inflammatory drug (NSAID) and analgesic COX enzymes and TRPV1 receptors Oncology, Pain management, and Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Ibuprofen and paracetamol (Ibuprofen and paracetamol) — Universidad Miguel Hernandez de Elche. Ibuprofen is a non-selective COX inhibitor, while paracetamol is a weak inhibitor of COX enzymes and also acts on TRPV1 receptors.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ibuprofen and paracetamol TARGET	Ibuprofen and paracetamol	Universidad Miguel Hernandez de Elche	phase 2	Nonsteroidal anti-inflammatory drug (NSAID) and analgesic	COX enzymes and TRPV1 receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nonsteroidal anti-inflammatory drug (NSAID) and analgesic class)

Universidad Miguel Hernandez de Elche · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ibuprofen and paracetamol — Competitive Intelligence Brief. https://druglandscape.com/ci/ibuprofen-and-paracetamol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab